Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis
NCT ID: NCT01772667
Last Updated: 2020-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2013-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
NCT04257630
Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation
NCT03477526
Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01715337
Rehabilitation in Patients With Pulmonary Fibrosis
NCT06677047
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
NCT00692796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Usual care during the whole study period without pulmonary rehabilitation. The patients will perform their normal daily life.
No interventions assigned to this group
Inpatient Rehabilitation
3-week inpatient multimodal pulmonary rehabilitation program, including daily exercise training, breathing therapy, medical treatment and psychological support. In the following 3 month, the patients will perform their normal daily life.
Inpatient Rehabilitation
Rehabilitation program in "Schoen Klinik Berchtesgadener Land"
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inpatient Rehabilitation
Rehabilitation program in "Schoen Klinik Berchtesgadener Land"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with idiopathic pulmonary fibrosis (vital capacity \> 50% pred.)
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schön Klinik Berchtesgadener Land
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Kenn
Head physician of the Department of Pulmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Kenn, MD
Role: STUDY_DIRECTOR
Head physician in the department of pulmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fibrosis2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.